James G. Marken
2017
In 2017, James G. Marken earned a total compensation of $875.5K as Senior Vice President, Operations and Product Development at ANI Pharmaceuticals, a 36% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $144,000 |
|---|---|
| Option Awards | $186,760 |
| Salary | $353,342 |
| Stock Awards | $179,474 |
| Other | $11,919 |
| Total | $875,495 |
Marken received $353.3K in salary, accounting for 40% of the total pay in 2017.
Marken also received $144K in non-equity incentive plan, $186.8K in option awards, $179.5K in stock awards and $11.9K in other compensation.
Rankings
In 2017, James G. Marken's compensation ranked 9,614th out of 14,666 executives tracked by ExecPay. In other words, Marken earned more than 34.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,614 out of 14,666 | 34th |
Division Manufacturing | 3,701 out of 5,772 | 36th |
Major group Chemicals And Allied Products | 1,282 out of 2,075 | 38th |
Industry group Drugs | 1,031 out of 1,731 | 40th |
Industry Pharmaceutical Preparations | 811 out of 1,333 | 39th |
Source: SEC filing on April 6, 2018.
Marken's colleagues
We found three more compensation records of executives who worked with James G. Marken at ANI Pharmaceuticals in 2017.
News
ANI Pharmaceuticals CEO Nikhil Lalwani's 2021 pay jumps 76% to $6.5M
March 25, 2022
ANI Pharmaceuticals CEO Nikhil Lalwani receives $3.7M in 2020
April 29, 2021
ANI Pharmaceuticals CEO Arthur Przybyl's 2019 pay jumps 39% to $5.8M
April 23, 2020
ANI Pharmaceuticals CEO Arthur Przybyl's 2018 pay rises 17% to $4.2M
April 4, 2019